CURARAD

Welcome to the Brand page for “CURARAD”, which is offered here for Providing software as a service (saas) services featuring software for use in medical diagnostics, medical image analysis, medical screening, medical testing, dna screening for medical purposes, and genetic testing for medical purposes; providing software as a service (saas) services featuring software for the analysis of medical data, medical imaging data, health care data, health records, medical records, and genomic data for use in the prevention, diagnosis and treatment of medical conditions, analyzing clinical trials, analyzing drug interactions, development of vaccines and medicines, analyzing medical diagnostic data, analyzing molecular medicine data, analyzing precision medicine data, and structural and functional analysis of genomes; providing software as a service (saas) services featuring software for the analysis of genomic data for use in tracking variation and mutation of pathogens; providing software as a service (saas) services featuring software for determining and predicting patterns in data, medical data, genomic data, proteomic data, metabolomics data, transcriptomic data, nutritional and nutrigenomics data, medical imaging data, health care data, health records, medical records, genomic data, and environmental factor data; providing software as a service (saas) services featuring software for executing preconfigured non-field specific machine learning and deep learning algorithms and processes for the purposes of uploading and managing data for the training of preconfigured data models implemented on a hosted software platform utilizing said machine learning and deep learning processes and for utilizing said trained data models for use in medical diagnostics, medical image analysis, medical screening, medical testing, dna screening for medical purposes, and genetic testing for medical purposes; providing software as a service (saas) services featuring software for conducting natural language processing on medical records to transform unstructured data into structured data supporting clinical and research use; research, development, testing, and deployment of immunotherapy drugs all being pharmaceutical drug development services; platform as a service (paas) featuring computer software platforms for providing clinical decision support for patient care; providing scientific analysis in the field of next generation sequencing (ngs), the analysis and interpretation of genomic data;.

Its status is currently believed to be active. Its class is unavailable. “CURARAD” is believed to be currently owned by “KEYAMED NA INC.”